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Abstract: Efficient synthesis of benzo[b]thiophenes from o-halophenyl acetonitrile has been 
achieved. This novel one-pot procedure involves CuI and pivalic acid catalyzed C-S bond 
formation using dithioesters followed by a heterocyclization reaction. This efficient protocol 
has the advantages of one-pot synthesis, short reaction time, good yields (62-78%) and 
operational simplicity. 
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Benzo[b]thiophene derivatives are important heterocyclic compounds because of their various 
applications in medicinal chemistry and material science.
1 
They represent important heterocyclic 




















The 2-arylbenzo[b]thiophene derivatives 







Recently a few 2-arylbenzo[b]thiophenes are 
marketed under the trademark Evista, and these are a class of compounds known as selective 
estrogen receptor modulators (SERM’S).  
 
 
Figure 1 Examples of biologically important benzo[b]thiophenes. 
 
In addition to this, Benzothiophene 3-carbonitrile and corresponding acids have found 
significant use as building blocks for the synthesis of pharmaceutically important 
molecules.
14a
 Thus, development of general methods for the synthesis of these compounds is 
valuable in drug discovery. Many methods
14b-i 
are reported for the synthesis of 
benzo[b]thiophene and their derivatives such as thiophenol derivatives 2-
chlorobenzaldehyde, 2-nitrobenzaldehydes, and alkynyl thiophenols. 
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The C–S bond formation reactions catalyzed by transition metals
15a







have been reported during the last few years. Nevertheless, the development 
of Cu-catalyzed methods for C–S bond formation is still attractive owing to the advantages of 
copper over other metals, like its price and minor toxicity. Sekar and co workers
11
 reported 
the synthesis of benzothiophenes and benzothiozoles in moderate to good yields via copper 
catalyzed reactions. Recently, Ila et al
17
 reported synthesis of 2,3-disubstituted 
benzo[b]thiophenes by intramolecular radical cyclization of 2-(o-bromoaryl)acrylonitriles 
derived from o-bromoarylacetonitriles  using two steps (Scheme 1). Consequently, the 
development of facile and novel route for the synthesis of these sulfur-based heterocycles is 
of high interest. 
 
 
Scheme 1 Synthetic route to 2,3-disubstituted Benzo[b]thiophenes 
 
Most of these reported methods involve, hazardous reagents, solvents and this synthetic 
strategy requires multistep reaction sequence. This encouraged us to consider for a direct 
reaction in the synthesis of functionalized benzo[b]thiophenes. In continuation of our work 
on synthesis of heterocyclic compounds,
18 
 herein, we report a novel method to access to 
benzothiophenes from range of dithioesters via-S-arylation 
 
            
Table 1 Optimization of reaction conditions for synthesis of 2-Phenylbenzo[b]thiophene-3-
carbonitrile (3a) 
Entry      Cu catalyst  Pivalic acid Base (equiv) Temp 
o
C 
Time in h  yield(%) 
1 - 1.5 eq K2CO3 (2) Reflux 24 - 
2 CuI (20 mol%) 1.5 eq        NaH (2 ) Reflux 24 54 
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3 CuI (20 mol%) 1.5 eq t-BuOK (2) Reflux 24 55 
4 CuI (20 mol%) 1.5 eq Cs2CO3 (2) Reflux 24 20 
5 CuI (20 mol%) 1.5 eq K3PO4 (2) Reflux 4 55 
6 CuI (20 mol%) 1.5 eq K3PO4 (2) 100 6 58 
7 CuI (20 mol%) 1.5 eq K3PO4 (2) 80 6 62 
8 CuI (20 mol%) 1.5 eq K3PO4 (2) 70 24 57 
9 CuI (50 mol%) 1.5 eq K3PO4 (2) 80 6 60 
10 CuI (10 mol%) 1.5 eq K3PO4 (2) 80 6 57 
11 - 1.5 eq K3PO4 (2) 80 6 25 
12 CuI (20 mol%) 1.0 eq K3PO4 (2) 80 6 55 
13 CuI (20 mol%) - K3PO4 (2) 80 6 - 
14 CuI (20 mol%) 2.0 eq K3PO4 (2) 80 6 57 
15 CuI (20 mol%) 1.5 eq - 80 6 - 
16 CuI (20 mol%) 1.5 eq   K3PO4 (1.5) 80 6 58 
17 CuI (20 mol%) 1.5 eq   K3PO4 (2.5) 80 6 60 
18 CuBr (20 mol%) 1.5 eq       K3PO4 (2 ) 80 6 52 
19 CuOAc (20 mol%) 1.5 eq       K3PO4 (2) 80 6 48 
aGeneral conditions: 1a (1.0 mmol), 1b (1.0 mmol) K3PO4 (2.0 mmol), in  DMF, CuI (20 mol%),  
pivalic acid (1.5 eq);  Yields are isolated yields of chromatographically purified compounds.  
 
 We set out to identify the possible mild conditions under which, the reaction of o -
chlorophenyl acetonitrile 1a and phenyl dithioester 2a would proceed with synthetically 
useful rate. The reaction requirements including catalysts, bases and additives were screened 
and the results are listed in Table 1. Initially, the condensation of o-chlorophenyl acetonitrile 
1a with phenyl dithioester 2a was examined in DMF with pivalic acid (1.5 equiv) as an 
additive, K2CO3 (1.5 equiv) as a base, in the absence of CuI, and at reflux, the intermediate 
product (E)-2-(2-bromophenyl)-3-mercapto-3-phenylacetonitrile was isolated in 52% yield. 
Different inorganic bases were evaluated and results are summarized in (Table 1, entries 1-5). 
A good result was obtained in presence of K3PO4, when the yield of 3a was increased to 62% 
(Table 1, entries 5-7). In contrast, no product could be found when organic bases, such as 
Et3N and pyridine were used. Remarkably, the reaction was found to proceed efficiently at 80 
o
C. In fact, the highest yield of 3a (62%) was observed at this point. A reduction in the 
loading of K3PO4 showed negative effect on the yield of 3a (Table 1, entry 16), whereas 
increasing to 2.5 equiv of K3PO4 did not offer any significant advantage over that of 2 equiv 
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(Table 1, entry 17). Preliminary studies revealed that only DMF, among a variety of other 
solvents like toluene, DMSO, acetonitrile and THF has proved to give optimal results. 
We evaluated the effect of catalyst on the reaction rate and yield, the reaction was found to 
proceed efficiently in the presence of CuI giving the highest yield of 3a (62%). An increase 
in the loading to 50 mol% failed to offer any significant advantages over the 20 mol% 
catalyst loading (Table 1, entry 9). A reduction in the loading of CuI showed negative effect 
on the yield of 3a (Table 1, entry 10), whereas the yield was drastically decreased in the 
absence of CuI, (Table 1, entry 11). Other copper salts were also tested but CuI remained as 
the best one (Table 1, entries 18-19). In another set of experiments, effect of additive was 
tested. A reduction in the loading of pivalic acid had a negative effect on the yield of 3a 
(Table 1, entry 12), whereas increasing to 2 equiv did not offer any significant advantages 
over that of 1.5 equiv catalyst loading (Table1, entry 14). No product was obtained in the 
absence of pivalic acid (Table1, entry 13). 
Copper-catalysed nitrogen free intramolecular C-S bond formation was shown to proceed 
efficiently with the combination of K3PO4 as a base and pivalic acid as an additive. With the 
optimized reaction conditions established, the substrate scope was examined, and results are 
summarized in (Table 2). Different dithioesters with electron-donating and electron-
withdrawing groups on the benzene ring reacted smoothly with o-halophenyl acetonitriles to 
give the corresponding 2-phenylbenzo[b]thiophenes in moderate to good yields at 80 
o
C 
(Table 2). This reaction was not limited to aromatic dithioesters, but heterocyclic dithioester 
also underwent the reaction equally under mild conditions.  
Table 2 Synthesis of 2-aryl/(het) aryl-3-cyanobenzo[b] thiophenes using o-
halophenylacetonitrile and dithioesters.  
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General conditions: 1a (1.0 mmol), 1b (1.0 mmol) K3PO4 (2.0 mmol), in DMF, CuI (20 mol%), pivalic acid 
(1.5 eq);  bYields are isolated yields of chromatographically purified compounds.  
 
The existence of other halides, such as F and Cl had no significant effect on the reaction, and 
the desired products were obtained in good yields, (Table 2, entries 7-10), notably, hydroxyl 
and methoxy were tolerated in the reaction, and the products were obtained in good yields 
(Table 2, entries 3,4,6 and 16).  
A plausible reaction mechanism for the CuI catalyzed domino reaction is presented in 
Scheme 2. It is assumed that, the reaction starts with abstraction of proton from active 
methylene compound o-chlorophenylacetonitrile followed by the substitution.
19
 The second 
step, is initiated by the reaction of A with K3PO4 to give the corresponding potassium enolate 
B Later intramolecualr S-arylation between S atom of enolate ion and aromatic carbon 
carrying the halogen atom is carried out by the oxidative addition of aryl chloride, to copper 
takes place and C is formed as an intermediate. This is followed by exchange of a pivalate for 
the chloride ligand to give D.
20
 In the final step D undergoes reductive elimination with the 
formation of benzothiophene 3a and regeneration of CuI.  


























































Scheme 2: Probable Mechanism for Formation of Benzo[b]thiophenes 
Conclusion: In summary, we are successful in developing a new efficient method to produce 
substituted benzothiophene derivatives via copper (I)-catalysed intramolecular C-S bond 
formation. The overall process is facilitated by the combined action of CuI, K3PO4, and 
pivalic acid. This approach is valuable alternative to widely used thiophenol reactions. This 
method is complimentary to existing methods for the benzothiophenes. Also, this versatile 
methodology will be a good alternative for the synthesis of Raloxifene analogues.   
 
Experimental section: 
General procedure for the synthesis of 2,3-substituted benzo[b] thiophenes: To a solution of 
2-(2-chlorophenyl)acetonitrile (1a) (1.0 mmol), methyl benzodithioate (2b) (1.0 mmol) in 
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DMF (2 mL), K3PO4 (2.0  mmol), pivalic acid (1.5 mmol), cuprous iodide (0.2 mmol) were 
added. The mixture was stirred at 80 
o
C and progress was monitored by TLC. When the 
dithioesters could no longer be detected, the reaction mixture was extracted with EtOAc 
(3×10 mL). The organic layer was dried over anhydrous Na2SO4. The solvent was then 
removed under reduced pressure and the residue was purified by silica gel chromatography. 
2-phenylbezo[b]thiophene-3-carbonitrile (3a) White solid; yield: 146 mg (62%); MP 
172−173 
o
C; Rf= 0.49 (hexane−EtOAc, 9:1). IR (KBr): 2217, 3070, 1608, 1589, 1484, 1318, 






NMR (400 MHz, CDCl3): δ = 7.12−7.16 (m, 
1H), 7.40−7.53 (m, 5H), 7.64 (d, J = 7.6 Hz, 1H), 7.81 (d, J = 8.0 Hz, 1H), 7.93 (d, J = 7.6 
Hz, 1H).; 
13
C NMR (100 MHz, CDCl3): δ =114.0, 119.4, 122.2, 123.5, 124.2, 124.4, 126.4, 
128.2, 128.9, 134.3, 139.5, 140.6, 144.2. MS: m/z= 235 [M + H]
+
 Anal.Cald for C15H9NS: C, 
76.57; H; 3.86; N; 5.95. Found: C, 76.55; H; 3.82; N; 5.91. 
 
2-(p-tolyl)benzo[b]thiophene-3-carbonitrile (3b) White solid; yield: 170 mg  (68%); MP 
166−167 
o
C; Rf= 0.53 (hexane−EtOAc, 9:1); IR (KBr): 2270, 3069, 2925, 1608, 1494, 1343, 
1217, 1191, 1065, 941, 859, 746, 687, 617 cm
-1;  1
H NMR (400 MHz CDCl3): δ = 7.34 (d, J = 
10.0 Hz, 2H), 7.42−7.46 (m, 1H), 7.54−7.50 (m, 1H) 7.79−7.85 (m, 3H) 7.97 (d, J = 10.0 Hz, 
1H); 
13
C NMR (100 MHz, CDCl3) δ = 21.2, 114.0, 118.8, 122.2, 123.3, 124.0, 124.4, 126.3, 
129.6, 131.5, 138.2, 139.3, 140.7, 144.4; MS: m/z= 249 [M + H]
+
; Anal.Cald for C16H11NS: 
C, 77.07; H, 4.45; N, 5.62. Found: C, 77.09; H, 4.40; N, 5.68. 
 
2-(4-methoxyphenyl)benzo[b]thiophene-3-carbonitrile (3c) White solid; yield: 173 mg 
(65%); MP 192−194 
o
C; Rf= 0.46 (hexane−EtOAc, 9:1); IR (KBr): 3095, 2220, 1609, 1528, 




H NMR (400 MHz CDCl3): δ = 
3.89 (s, 3H), 7.02−7.05 (m, 2H), 7.41−7.45 (m, 1H), 7.49−7.53 (m, 1H), 7.81−7.87 (m, 1H), 
7.93 (d, J = 4.5 Hz, 1H); 
13
C NMR (100 MHz, CDCl3): δ = 55.4, 100.7, 114.7, 115.4, 122.2, 
122.3, 124.0, 125.8, 125.9, 129.6, 136.9, 139.9, 155.1, 161.4; MS: m/z= 266 [M + H]
+
. 
Anal.Cald for C16H11NOS: C, 72.43; H, 4.18; N, 5.28; Found: C, 72.47; H, 4.13; N, 5.24. 
 
2-(4-metoxyphenyl)-6-(trifluromethyl)benzo[b]thiophene]-3-carbonitirle (3d) White 
solid; yield:  254 mg (76%); MP 204−206 
o
C; Rf= 0.55 (hexane−EtOAc, 9:1); IR (KBr): 




H NMR (500 MHz, CDCl3): δ 
= 3.90 (s, 3H), 7.06 (t J =2.5 Hz, 1H), 7.72−7.75 (m, 1H), 7.86−7.89 (m, 2H), 8.03 (d, J = 
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10.5 Hz, 1H), 8.11 (d, J = 3.8 Hz, 1H); 
13
C NMR (100 MHz, CDCl3): δ = 55.6, 119.8, 122.5, 
122.8 (q, JC-F = 37.5 Hz, 1C), 122.9, 123.2, 125.4, 127.9, 128.1, 128.6, 129.8, 130.0, 136.6, 
141.8, 158.2; MS: m/z= 333 [M]
+
; Anal.Cald for C17H10F3NOS: C, 61.26; H, 3.02; N, 4.20. 
Found: C, 61.22; H, 3.08; N, 4.26 
 
2-(p-tolyl)-6-((trifluromethyl)benzo[b]thiophene]-3-carbonitirle (3e) White solid; yield: 
225 mg (71%); MP 183−185 
o
C; Rf = 0.52 (hexane−EtOAc, 9:1); IR (KBr): 2217, 1593, 




H NMR (500 MHz CDCl3): δ = 2.32 
(s, 3H), 7.27 (d, J = 7.5 Hz, 2H), 7.67 (d, J = 8.5 Hz, 1H), 7.73 (d, J = 7.5 Hz, 2H), 7.97 (d, J 
= 8.5 Hz, 1H), 8.04 (s, 1H); 
13
C NMR (125 MHz, CDCl3): δ = 114.9, 120.06, 120.09, 123.10, 
123.41 (q,JC-F = 38.7Hz,1C), 123.48 123.7, 125.2, 128.31, 128.34, 130.4, 137.1, 141.8, 142.6, 
158.6; MS: m/z= 317 [M]
+
; Anal.Cald for C17H10F3NS: C, 64.34; H, 3.18; N, 4.41. Found: C, 
64.37; H, 3.25; N, 4.46. 
 
2-(3,4,5-trimethoxyphenyl)benzo[b]thiophene]-3-carbonitirle (3f) White solid; yield: 231 




C; Rf= 0.42 (hexane−EtOAc, 9:1); IR (KBr): 3095, 2220, 1609, 




H NMR (500 MHz, 
CDCl3): δ = 3.79−3.82 (m, 3H), 3.84−3.92 (m, 6H), 7.04 (s, 2H), 7.33−7.37 (m, 1H), 7. 
41−7.45 (m, 1H), 7.72− 7.75 (m, 1H), 7.84−7.87 (m, 1H); 
13
C NMR (100 MHz, CDCl3): δ = 
56.2, 60.8, 61.0, 101.6, 105.5, 115.3, 122.1, 122.3, 122.59, 125.91, 126.2, 126.7, 137.0, 
139.1, 140.1, 153.6, 155.0; MS: m/z= 326 [M + H]
+
; Anal.Cald for C18H15NO3S: C, 66.44; H, 
4.65; N, 4.30; Found: C, 66.47; H, 4.72; N, 4.35 
 
2-(4-Chlorophenyl)benzo[b]thiophene-3-carbonitrile (3g) White solid; yield: 234 mg 
(78%); MP 191−193 
o
C; Rf = 0.59 (hexane−EtOAc, 9:1); IR (KBr): 2217, 1608, 1589, 1484, 




H NMR (400 MHz CDCl3): δ = 7.46−7.57 
(m, 4H), 7.82−7.87 (m, 3H), 7.97−7.99 (m, 1H); 
13
C NMR (125 MHz, CDCl3): δ = 102.5, 
114.9, 122.4, 122.7, 126.3, 126.4, 129.5, 129.7, 130.0, 136.7, 137.4, 139.1, 153.5; MS: m/z= 
270 [M + H]
+
; Anal.Cald for C15H8ClNS: C, 66.79; H, 2.99; N, 5.19. Found: C, 66.74; H, 
2.93; N, 5.16. 
 
2-(4-Chlorophenyl)-6-(trifluromethyl)benzo[b]thiophene-3-carbonitrile (3h) White solid; 
yield: 205 mg (61%); MP 212−214 
o
C; Rf = 0.58 (hexane−EtOAc, 9:1); IR (KBr): 2919, 




H NMR (400 MHz 
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CDCl3): δ = 7.52−7.55 (m, 2H), 7.76−7.79 (m, 1H), 7.83 7.87 (m, 2H), 8.09 (d, J = 10.5 Hz, 
1H), 8.15 (d, J = 4.0 Hz, 1H); 
13
C NMR (100 MHz, CDCl3): δ = 102.4, 114.4, 120.1, 122.6, 
122.9, 123.6 (q, JC-F = 40 Hz, 1C), 124.0, 128.6, 128.9, 129.4, 137.1,137.6, 141.5, 156.6; MS: 
m/z= 337 [M]
+
; Anal.Cald for C16H7ClF3NS: C, 56.90; H, 2.09; N, 4.15. Found: C, 56.95; H, 
2.15; N, 4.18. 
 
2-(4-Flurophenyl)-6-(trifluromethyl)benzo[b]thiophene-3-carbonitrile (3i) White solid; 
yield  240 mg (75%); MP 216−218 
o
C; Rf= 0.40 (hexane−EtOAc, 9:1); IR (KBr): 2962, 2215, 




H NMR (400 MHz, 
CDCl3): δ = 7.20 (t, J = 10.5 Hz, 2H), 7.07 (d, J = 10.5 Hz, 1H), 7.81−7.85 (m, 2H), 8.00 (d, 
J = 9.8 Hz, 1H), 8.07 (s, 1H); 
13
C NMR (100 MHz, CDCl3): δ = 114.3, 119.8, 122.5, 123.1, 
123.7 (q, JC-F = 60 Hz,1C), 124.3, 127.0, 128.7, 129.8, 130.4, 141.4, 156.7, 163.0, 164.5 (d, 
JC-F =150Hz 1C); MS: m/z = 321 [M]
+
; Anal.Cald for C16H7F4NS: C, 59.81; H, 2.20; N; 4.36. 
Found: C, 59.85; H, 2.25; N; 4.38. 
 
2-(4-flurophenylbezo[b]thiophene-3-carbonitrile (3j) White solid; yield: 167 mg (66%); 
MP 161−163 
o
C; Rf= 0.57 (hexane−EtOAc, 9:1); IR (KBr): 2282, 2215, 1460, 1436, 1318, 




H NMR (500 MHz CDCl3): δ = 7.81 (d, J = 7.5 
Hz, 1H), 7.76 (d, J = 8.0 Hz, 1H), 7.68−7.65(m, 1H), 7.46 (s, 1H), 7.35-7.31 (m, 2H), 
7.13−7.10 (m, 2H); 
13
C NMR (125 MHz, CDCl3): δ = 115.8, 116.0, 119.4, 122.2, 123.5, 
124.3, 128.1, 128.2, 130.56, 140.6, 143.0, 161.7, 162.0 (d, JC-F = 238 Hz 1C); MS: m/z= 254 
[M + H]
+
; Anal.Cald for C15H8FNS: C, 71.13; H, 3.18; N, 5.53. 
 
2-(4-(trifluromethyl)phenyl)benzo[b]thiophene-3-carbonitrile (3k) White solid; Yield: 
203 mg (67%); MP 216−218 
o
C; Rf= 0.46 (hexane−EtOAc, 9:1); IR (KBr): 2217, 2,231, 
3070, 1608, 1589, 1484, 1318, 1176, 1231, 1197, 1064, 943, 878, 744, 614; 
1
H NMR (500 
MHz, CDCl3): δ = 7.85 (d, J = 8.0 Hz, 1H),7.82−7.80 (m 3H), 7.67 (d, J = 8.5 Hz, 2H), 7.63 
(s, 1H), 7.40−7.34 (m, 1H); 
13
C NMR (125 MHz, CDCl3): δ =114.0, 121.9, 122.9, 123.9, 
124.9, (q, JC-F = 103.2 Hz, 1C), 125.1, 125.8, 126.0, 129.8, 130.1, 137.7, 139.8, 140.4, 142.3; 
MS: m/z= 303 [M]
+
; Anal.Cald for C16H8F3NS: C, 63.36; H, 2.66; N, 4.62. Found: C, 63.33; 
H, 2.63; N, 4.66 
 
2,6-bibenzo[b]thiophene]-3-carbonitrile (3l) White solid; yield: 209 mg (72%); MP 
153−155 
o
C; Rf= 0.54 (hexane−EtOAc, 9:1); IR (KBr): 3082, 2215, 1531, 1456, 1318, 1256, 
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H NMR (500 MHz, CDCl3): δ = 7.46−7.52 (m, 3H), 
7.53−7.60 (m, 1H), 7.92 (d, J = 8.0 Hz, 2H), 7.95−7.97 (m, 2H), 8.04-8.15 (m,1H), 8.14−8.16 
(m, 1H); 
13
C NMR (125 MHz, CDCl3): δ = 114.7, 122.6, 122.8, 123.0, 125.1, 125.3, 126.2, 
126.9, 129.35, 129.3, 136.6, 137.8, 138.2, 138.2, 140.4, 148.2; MS: m/z= 292 [M + H]
+
; 
Anal.Cald for C17H9NS2: C, 70.07; H, 3.11; N, 4.81. Found: C, 70.04; H, 3.18; N, 4.86. 
 
2-(thiophenyl-2-yl)-6-(trifluoromethyl)benzo[b]thiophene-3-carbonitrile (3m) White 
solid; Yield: 219 mg (71%); MP 147−148 
o
C; Rf= 0.57 (hexane−EtOAc, 9:1); IR (KBr): 





(400 MHz, CDCl3): δ = 7.20−7.22 (m, 1H), 7.59, (dd, J = 7.5, 5.0 Hz, 1H), 7.73−7.75 (m, 
1H), 7.84, (dd, J = 6.3, 5.0 Hz, 1H), 8.02 (d, J = 10.5 Hz, 1H), 8.08 (t, J = 0.5 Hz, 1H);  
13
C NMR (100 MHz, CDCl3): δ = 114.4, 119.6, 122.5, 122.8 (q, JC-F = 36.1 Hz, 1C), 123.1, 
123.4, 128.3, 128.6, 129.4, 129.9, 132.8, 136.2, 141.2, 150.6; MS: m/z= 309 [M]
+
; Anal.Cald 
for C14H6F3NS2: C, 54.36; H, 1.96; N, 4.53. 
 





C; Rf= 0.50 (hexane−EtOAc, 9:1); IR (KBr): 2217, 1606, 1533, 1497, 




H NMR (500 MHz, CDCl3): δ = 
7.17−7.19 (m, 1H,), 7.45 (t, J = 9.5 Hz, 1H), 7.53 (t, J = 7.0 Hz, 2H), 7.80 (t, J = 10.5 Hz, 
2H), 7.92 (d, J = 10 Hz, 1H); 
13
C NMR (100 MHz, CDCl3): δ = 115.0, 122.1, 122.4, 126.2, 
128.4, 128.6, 128.63, 128.8, 128.9, 133.5, 136.6, 138.8, 147.6; MS: m/z= 242 [M+H]
+
; 
Anal.Cald for C13H7NS2: C, 64.70; H, 2.92; N, 5.80; Found: C, 64.79; H, 2.96; N, 5.88. 
 
6-trifluromethyl)-[2,6-bibenzo[b]thiophene]-3-carbonitirle (3o) White solid; yield: 248 
mg (69%); MP 159−160 
o
C; Rf = 0.44 (hexane−EtOAc, 9:1); IR (KBr): 2915, 2848, 2214, 




H NMR (400 MHz CDCl3) δ = 
7.46−7.54 (m, 2H), 7.79−7.88 (m, 1H), 7.95−7.97 (m, 1H), 8.10−8.14 (m, 3H), 8.19 (m, 1H); 
13
C NMR (100 MHz, CDCl3): δ = 114.2, 119.9, 122.1, 122.5 (q, JC-F = 45.5 Hz,1C), 122.6, 
123.0, 125.2, 126.3, 128.3, 128.7, 130.23, 130.24, 136.3, 137.4, 140.5, 151.2; MS: m/z= 359 
[M]
+
; Anal.Cald for C18H8F3NS2: C, 60.16; H, 2.24; N, 3.90. 
 
2-(4-hydrxoyphenyl)benzo[b]thiophene-3-carbonitrile (3p) White solid; Yield: 158 mg 
(63%); MP 203 
o
C; Rf= 0.49 (hexane−EtOAc, 9:1) IR (KBr): 2217, 3070, 3650, 1608, 1589, 
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H NMR (400 MHz CDCl3) δ = 
6.99−7.50 (m. 2H), 7.50−7.52(m, 1H), 7.54−7.61 (m, 1H), 7.75−7.70 (m, 2H), 7.65−7.67 (m, 
1H), 8.11−8.14 (m, 1H), 10.31 (s, 1H); 
13
C NMR (100 MHz, CDCl3): δ = 104.2, 114.4, 
119.6, 120.4, 121.5, 121.6, 126.8, 128.0, 134.7, 135.0, 141.4, 143.6, 160.8, 165.0; MS: m/z= 
251 [M]
+
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